BVT Knock-Out BIIB/ DE000VD40TW5 /
2024-05-09 8:43:21 PM | Chg.+0.02 | Bid9:40:09 PM | Ask9:40:09 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
2.45EUR | +0.82% | 2.50 Bid Size: 30,000 |
2.53 Ask Size: 30,000 |
Biogen Inc | 197.72 USD | 2078-12-31 | Call |
GlobeNewswire
3:31 PM
US Neurologists Report Route of Administration as a Critical Factor when Evaluating Future Parkinson...
GlobeNewswire
05-08
C4 Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
GlobeNewswire
05-07
Denali Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
GlobeNewswire
04-29
Muscular Dystrophy Association Launches ALS Awareness Month with Public Service Announcement ‘Answer...
GlobeNewswire
04-25
Biogen Receives Positive CHMP Opinion for TOFIDENCE™ (tocilizumab), a Biosimilar Referencing ROACTEM...
GlobeNewswire
04-23
Recludix Pharma Announces the Appointment of Dr. Ajay Nirula, Accomplished Pharma Executive and Immu...
GlobeNewswire
03-13
Voyager Therapeutics Announces Appointment of Toby Ferguson as Chief Medical Officer
GlobeNewswire
03-11
Hyku Biosciences, a Covalent Precision Medicine Company, Announces CEO Transition for its Next Phase...
GlobeNewswire
03-08
From the Beach to the Boardroom: Unispace's 'Art for Impact' Program Partners with NGO to Turn 50,00...